Eledon Pharmaceuticals Ownership 2024 | Who Owns Eledon Pharmaceuticals Now?
Institutional Ownership
60.89%
Insider Ownership
3.41%
Retail Ownership
35.70%
Institutional Holders
31.00
Eledon Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BVF INC/IL | 20.98% | 0.47% | 6,293,282 | 1,966,572 | 45.45% | 16,614,264 | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | 7.79% | 0.08% | 2,336,000 | 39,000 | 1.70% | 6,167,040 | Jun 30, 2024 |
ZIMMER PARTNERS, LP | 7.03% | 0.10% | 2,109,704 | 2,109,704 | 100.00% | 5,569,619 | Jun 30, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 5.00% | 0.03% | 1,500,000 | 1,449,200 | 2852.76% | 3,960,000 | Jun 30, 2024 |
SPHERA FUNDS MANAGEMENT LTD. | 4.32% | 0.47% | 1,297,021 | 1,297,021 | 100.00% | 3,424,135 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.68% | 0.00% | 1,104,395 | 135,274 | 13.96% | 2,915,603 | Jun 30, 2024 |
WOODLINE PARTNERS LP | 2.25% | 0.02% | 675,243 | 23,304 | 3.57% | 1,782,642 | Jun 30, 2024 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 2.00% | 0.09% | 600,000 | 600,000 | 100.00% | 1,584,000 | Jun 30, 2024 |
ALYESKA INVESTMENT GROUP, L.P. | 1.67% | 0.01% | 500,000 | 500,000 | 100.00% | 1,320,000 | Jun 30, 2024 |
ENSIGN PEAK ADVISORS, INC | 1.48% | 0.00% | 443,001 | - | - | 1,169,523 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 1.15% | 0.00% | 344,489 | 163,588 | 90.43% | 909,619 | Jun 30, 2024 |
STATE STREET CORP | 0.54% | - | 161,492 | 116,800 | 261.34% | 426,339,000 | Jun 30, 2024 |
CM MANAGEMENT, LLC | 0.53% | 0.39% | 160,000 | - | - | 422,400 | Jun 30, 2024 |
BLACKROCK INC. | 0.52% | - | 155,080 | 128,249 | 477.99% | 409,411 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.46% | 0.00% | 136,773 | 49,704 | 57.09% | 361,081 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.31% | - | 91,893 | 52,089 | 130.86% | 242,598,000 | Jun 30, 2024 |
JMAC ENTERPRISES LLC | 0.19% | 0.03% | 58,041 | - | - | 153,228 | Jun 30, 2024 |
UBS GROUP AG | 0.18% | - | 55,001 | 54,997 | 1374925.00% | 145,203 | Jun 30, 2024 |
INGALLS & SNYDER LLC | 0.17% | 0.01% | 51,849 | - | - | 137,000 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.11% | 0.00% | 33,400 | 33,400 | 100.00% | 88,176 | Jun 30, 2024 |
Eledon Pharmaceuticals's largest institutional shareholder is BVF INC/IL, holding 20.98% of the company's total share outstanding, currently valued at $16.61M. The top 10 institutional shareholders own together 56.22% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 4.32% | 0.47% | 1,297,021 | 1,297,021 | 100.00% | 3,424,135 | Jun 30, 2024 |
BVF INC/IL | 20.98% | 0.47% | 6,293,282 | 1,966,572 | 45.45% | 16,614,264 | Jun 30, 2024 |
CM MANAGEMENT, LLC | 0.53% | 0.39% | 160,000 | - | - | 422,400 | Jun 30, 2024 |
ZIMMER PARTNERS, LP | 7.03% | 0.10% | 2,109,704 | 2,109,704 | 100.00% | 5,569,619 | Jun 30, 2024 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 2.00% | 0.09% | 600,000 | 600,000 | 100.00% | 1,584,000 | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | 7.79% | 0.08% | 2,336,000 | 39,000 | 1.70% | 6,167,040 | Jun 30, 2024 |
JMAC ENTERPRISES LLC | 0.19% | 0.03% | 58,041 | - | - | 153,228 | Jun 30, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 5.00% | 0.03% | 1,500,000 | 1,449,200 | 2852.76% | 3,960,000 | Jun 30, 2024 |
WOODLINE PARTNERS LP | 2.25% | 0.02% | 675,243 | 23,304 | 3.57% | 1,782,642 | Jun 30, 2024 |
ALYESKA INVESTMENT GROUP, L.P. | 1.67% | 0.01% | 500,000 | 500,000 | 100.00% | 1,320,000 | Jun 30, 2024 |
MARCO INVESTMENT MANAGEMENT LLC | 0.10% | 0.01% | 30,344 | 5,535 | 22.31% | 80,108 | Jun 30, 2024 |
INGALLS & SNYDER LLC | 0.17% | 0.01% | 51,849 | - | - | 137,000 | Jun 30, 2024 |
ENSIGN PEAK ADVISORS, INC | 1.48% | 0.00% | 443,001 | - | - | 1,169,523 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.11% | 0.00% | 33,400 | 33,400 | 100.00% | 88,176 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.06% | 0.00% | 16,958 | 11,284 | 198.87% | 44,769 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.46% | 0.00% | 136,773 | 49,704 | 57.09% | 361,081 | Jun 30, 2024 |
PATHSTONE HOLDINGS, LLC | 0.04% | 0.00% | 13,029 | - | - | 34,397 | Jun 30, 2024 |
MERCER GLOBAL ADVISORS INC /ADV | 0.06% | 0.00% | 16,726 | - | - | 44,157 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 1.15% | 0.00% | 344,489 | 163,588 | 90.43% | 909,619 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.68% | 0.00% | 1,104,395 | 135,274 | 13.96% | 2,915,603 | Jun 30, 2024 |
The largest Eledon Pharmaceuticals shareholder by % of total assets is SPHERA FUNDS MANAGEMENT LTD.. The company owns 1.30M shares of Eledon Pharmaceuticals (ELDN), representing 0.47% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ZIMMER PARTNERS, LP | 7.03% | 0.10% | 2,109,704 | 2,109,704 | 100.00% | 5,569,619 | Jun 30, 2024 |
BVF INC/IL | 20.98% | 0.47% | 6,293,282 | 1,966,572 | 45.45% | 16,614,264 | Jun 30, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 5.00% | 0.03% | 1,500,000 | 1,449,200 | 2852.76% | 3,960,000 | Jun 30, 2024 |
SPHERA FUNDS MANAGEMENT LTD. | 4.32% | 0.47% | 1,297,021 | 1,297,021 | 100.00% | 3,424,135 | Jun 30, 2024 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 2.00% | 0.09% | 600,000 | 600,000 | 100.00% | 1,584,000 | Jun 30, 2024 |
ALYESKA INVESTMENT GROUP, L.P. | 1.67% | 0.01% | 500,000 | 500,000 | 100.00% | 1,320,000 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 1.15% | 0.00% | 344,489 | 163,588 | 90.43% | 909,619 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.68% | 0.00% | 1,104,395 | 135,274 | 13.96% | 2,915,603 | Jun 30, 2024 |
BLACKROCK INC. | 0.52% | - | 155,080 | 128,249 | 477.99% | 409,411 | Jun 30, 2024 |
STATE STREET CORP | 0.54% | - | 161,492 | 116,800 | 261.34% | 426,339,000 | Jun 30, 2024 |
UBS GROUP AG | 0.18% | - | 55,001 | 54,997 | 1374925.00% | 145,203 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.31% | - | 91,893 | 52,089 | 130.86% | 242,598,000 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.46% | 0.00% | 136,773 | 49,704 | 57.09% | 361,081 | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | 7.79% | 0.08% | 2,336,000 | 39,000 | 1.70% | 6,167,040 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.11% | 0.00% | 33,400 | 33,400 | 100.00% | 88,176 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.10% | - | 30,233 | 30,233 | 100.00% | 79,815 | Jun 30, 2024 |
WOODLINE PARTNERS LP | 2.25% | 0.02% | 675,243 | 23,304 | 3.57% | 1,782,642 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.06% | 0.00% | 16,958 | 11,284 | 198.87% | 44,769 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.02% | - | 6,818 | 6,818 | 100.00% | 18,000 | Jun 30, 2024 |
MARCO INVESTMENT MANAGEMENT LLC | 0.10% | 0.01% | 30,344 | 5,535 | 22.31% | 80,108 | Jun 30, 2024 |
As of Jun 30 2024, Eledon Pharmaceuticals's largest institutional buyer is ZIMMER PARTNERS, LP. The company purchased 2.11M stocks of ELDN, valued at $5.57M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | - | - | - | -13,875 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -189 | -100.00% | - | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
CM MANAGEMENT, LLC | 0.53% | 0.39% | 160,000 | - | - | 422,400 | Jun 30, 2024 |
JMAC ENTERPRISES LLC | 0.19% | 0.03% | 58,041 | - | - | 153,228 | Jun 30, 2024 |
INGALLS & SNYDER LLC | 0.17% | 0.01% | 51,849 | - | - | 137,000 | Jun 30, 2024 |
ENSIGN PEAK ADVISORS, INC | 1.48% | 0.00% | 443,001 | - | - | 1,169,523 | Jun 30, 2024 |
PATHSTONE HOLDINGS, LLC | 0.04% | 0.00% | 13,029 | - | - | 34,397 | Jun 30, 2024 |
MERCER GLOBAL ADVISORS INC /ADV | 0.06% | 0.00% | 16,726 | - | - | 44,157 | Jun 30, 2024 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.05% | - | 14,987 | - | - | 39,566 | Jun 30, 2024 |
MORGAN STANLEY | 0.01% | - | 2,155 | - | - | 5,689 | Jun 30, 2024 |
FMR LLC | 0.00% | - | 17 | - | - | 45 | Jun 30, 2024 |
JPMORGAN CHASE & CO | 0.00% | - | 91 | 35 | 62.50% | 240 | Jun 30, 2024 |
MARCO INVESTMENT MANAGEMENT LLC | 0.10% | 0.01% | 30,344 | 5,535 | 22.31% | 80,108 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.02% | - | 6,818 | 6,818 | 100.00% | 18,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.06% | 0.00% | 16,958 | 11,284 | 198.87% | 44,769 | Jun 30, 2024 |
WOODLINE PARTNERS LP | 2.25% | 0.02% | 675,243 | 23,304 | 3.57% | 1,782,642 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.10% | - | 30,233 | 30,233 | 100.00% | 79,815 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.11% | 0.00% | 33,400 | 33,400 | 100.00% | 88,176 | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | 7.79% | 0.08% | 2,336,000 | 39,000 | 1.70% | 6,167,040 | Jun 30, 2024 |
As of Jun 30 2024, Eledon Pharmaceuticals's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -13.88K shares of ELDN, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ZIMMER PARTNERS, LP | 7.03% | 0.10% | 2,109,704 | 2,109,704 | 100.00% | 5,569,619 | Jun 30, 2024 |
SPHERA FUNDS MANAGEMENT LTD. | 4.32% | 0.47% | 1,297,021 | 1,297,021 | 100.00% | 3,424,135 | Jun 30, 2024 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 2.00% | 0.09% | 600,000 | 600,000 | 100.00% | 1,584,000 | Jun 30, 2024 |
ALYESKA INVESTMENT GROUP, L.P. | 1.67% | 0.01% | 500,000 | 500,000 | 100.00% | 1,320,000 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.11% | 0.00% | 33,400 | 33,400 | 100.00% | 88,176 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.10% | - | 30,233 | 30,233 | 100.00% | 79,815 | Jun 30, 2024 |
Eledon Pharmaceuticals's largest new institutional shareholder by number of shares is ZIMMER PARTNERS, LP, purchased 2.11M shares, valued at $5.57M, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | - | - | - | -13,875 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -189 | -100.00% | - | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
Eledon Pharmaceuticals's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -13.88K shares, valued at -, as of undefined.
Eledon Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY ADVISOR SERIES VII | 0.01% | 114,789 | - | - | Jan 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 955,721 | 51,409 | 5.68% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 170,684 | 3,977 | 2.39% | Feb 29, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.00% | 42,236 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,263 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 14,987 | - | - | Jan 31, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 26,400 | - | - | Jan 31, 2024 |
Dimensional ETF Trust | 0.00% | 7,769 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 10,185 | - | - | Jan 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 2,323 | - | - | Jan 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 300 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,433 | - | - | Mar 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 333 | -449 | -57.42% | Mar 31, 2024 |
Eledon Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY ADVISOR SERIES VII", owning 114.79K shares, compromising 0.01% of its total assets.
Eledon Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 31 | 3.33% |
31 Mar, 24 | 30 | 3.45% |
31 Dec, 23 | 29 | 3.57% |
30 Sep, 23 | 28 | -15.15% |
30 Jun, 23 | 33 | 6.45% |
31 Mar, 23 | 31 | 10.71% |
31 Dec, 22 | 28 | -3.45% |
30 Sep, 22 | 29 | - |
30 Jun, 22 | 29 | -9.38% |
31 Mar, 22 | 32 | -8.57% |
31 Dec, 21 | 35 | 9.38% |
30 Sep, 21 | 32 | 3.23% |
30 Jun, 21 | 31 | -3.13% |
31 Mar, 21 | 32 | 3100.00% |
31 Dec, 20 | 1 | - |
As of 30 Jun 24, 31 institutions are holding Eledon Pharmaceuticals's shares, representing an increase of 3.33% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 18,259,810 | 90.30% |
31 Mar, 24 | 9,595,061 | 4.83% |
31 Dec, 23 | 9,153,168 | 2.64% |
30 Sep, 23 | 8,917,867 | -3.86% |
30 Jun, 23 | 9,275,490 | 48.63% |
31 Mar, 23 | 6,240,661 | -0.17% |
31 Dec, 22 | 6,251,160 | -0.27% |
30 Sep, 22 | 6,268,078 | -4.08% |
30 Jun, 22 | 6,534,651 | -6.71% |
31 Mar, 22 | 7,004,981 | -11.16% |
31 Dec, 21 | 7,884,711 | -6.52% |
30 Sep, 21 | 8,434,580 | -10.49% |
30 Jun, 21 | 9,423,462 | 13.29% |
31 Mar, 21 | 8,317,697 | 22933.69% |
31 Dec, 20 | 36,111 | - |
Eledon Pharmaceuticals (ELDN) has 18.26M shares outstanding as of 30 Jun 24, up 90.30% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 60.89% | 3.88% |
31 Mar, 24 | 39.63% | 4.25% |
31 Dec, 23 | 30.54% | 2.21% |
30 Sep, 23 | 37.15% | 0.88% |
30 Jun, 23 | 64.93% | 3.40% |
31 Mar, 23 | 43.68% | 2.28% |
31 Dec, 22 | 43.76% | 2.27% |
30 Sep, 22 | 43.94% | 2.09% |
30 Jun, 22 | 45.81% | 1.92% |
31 Mar, 22 | 48.88% | 1.73% |
31 Dec, 21 | 53.22% | 1.64% |
30 Sep, 21 | 56.93% | 1.41% |
30 Jun, 21 | 63.60% | 2.02% |
31 Mar, 21 | 56.08% | 94594.21% |
31 Dec, 20 | 0.24% | - |
As of 30 Jun 24, Eledon Pharmaceuticals is held by 60.89% institutional shareholders, representing a 3.88% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 21 | 90.91% |
31 Mar, 24 | 11 | -8.33% |
31 Dec, 23 | 12 | 9.09% |
30 Sep, 23 | 11 | -31.25% |
30 Jun, 23 | 16 | 60.00% |
31 Mar, 23 | 10 | 11.11% |
31 Dec, 22 | 9 | 28.57% |
30 Sep, 22 | 7 | 40.00% |
30 Jun, 22 | 5 | -54.55% |
31 Mar, 22 | 11 | -26.67% |
31 Dec, 21 | 15 | - |
30 Sep, 21 | 15 | -16.67% |
30 Jun, 21 | 18 | -41.94% |
31 Mar, 21 | 31 | 3000.00% |
31 Dec, 20 | 1 | - |
21 institutional shareholders have increased their position in ELDN stock as of 30 Jun 24 compared to 11 in the previous quarter (a 90.91% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 1 | -85.71% |
31 Mar, 24 | 7 | 16.67% |
31 Dec, 23 | 6 | -33.33% |
30 Sep, 23 | 9 | 80.00% |
30 Jun, 23 | 5 | 25.00% |
31 Mar, 23 | 4 | -50.00% |
31 Dec, 22 | 8 | -27.27% |
30 Sep, 22 | 11 | 10.00% |
30 Jun, 22 | 10 | 25.00% |
31 Mar, 22 | 8 | 33.33% |
31 Dec, 21 | 6 | -45.45% |
30 Sep, 21 | 11 | 83.33% |
30 Jun, 21 | 6 | - |
31 Mar, 21 | - | - |
31 Dec, 20 | - | - |
1 institutional shareholders have reduced their position in ELDN stock as of 30 Jun 24 compared to 7 in the previous quarter (a -85.71% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 31 | 3.33% | 18,259,810 | 90.30% | 60.89% | 3.88% | 21 | 90.91% | 1 | -85.71% |
31 Mar, 24 | 30 | 3.45% | 9,595,061 | 4.83% | 39.63% | 4.25% | 11 | -8.33% | 7 | 16.67% |
31 Dec, 23 | 29 | 3.57% | 9,153,168 | 2.64% | 30.54% | 2.21% | 12 | 9.09% | 6 | -33.33% |
30 Sep, 23 | 28 | -15.15% | 8,917,867 | -3.86% | 37.15% | 0.88% | 11 | -31.25% | 9 | 80.00% |
30 Jun, 23 | 33 | 6.45% | 9,275,490 | 48.63% | 64.93% | 3.40% | 16 | 60.00% | 5 | 25.00% |
31 Mar, 23 | 31 | 10.71% | 6,240,661 | -0.17% | 43.68% | 2.28% | 10 | 11.11% | 4 | -50.00% |
31 Dec, 22 | 28 | -3.45% | 6,251,160 | -0.27% | 43.76% | 2.27% | 9 | 28.57% | 8 | -27.27% |
30 Sep, 22 | 29 | - | 6,268,078 | -4.08% | 43.94% | 2.09% | 7 | 40.00% | 11 | 10.00% |
30 Jun, 22 | 29 | -9.38% | 6,534,651 | -6.71% | 45.81% | 1.92% | 5 | -54.55% | 10 | 25.00% |
31 Mar, 22 | 32 | -8.57% | 7,004,981 | -11.16% | 48.88% | 1.73% | 11 | -26.67% | 8 | 33.33% |
31 Dec, 21 | 35 | 9.38% | 7,884,711 | -6.52% | 53.22% | 1.64% | 15 | - | 6 | -45.45% |
30 Sep, 21 | 32 | 3.23% | 8,434,580 | -10.49% | 56.93% | 1.41% | 15 | -16.67% | 11 | 83.33% |
30 Jun, 21 | 31 | -3.13% | 9,423,462 | 13.29% | 63.60% | 2.02% | 18 | -41.94% | 6 | - |
31 Mar, 21 | 32 | 3100.00% | 8,317,697 | 22933.69% | 56.08% | 94594.21% | 31 | 3000.00% | - | - |
31 Dec, 20 | 1 | - | 36,111 | - | 0.24% | - | 1 | - | - | - |
Eledon Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
The last insider buy of ELDN was made by BVF PARTNERS L P/IL on May 13 2024, buying 1,031,385 shares at $2.37 per share (worth $2.44M).
Eledon Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 10 | - | - |
Q4 2023 | 2 | - | - |
Q2 2023 | 19 | - | - |
Q1 2023 | 11 | - | - |
Q4 2022 | 1 | - | - |
Q1 2022 | 10 | 8 | 125.00% |
Q4 2021 | 1 | - | - |
Q3 2021 | 1 | 1 | 100.00% |
Q2 2021 | 3 | - | - |
Q1 2021 | - | 1 | - |
Q4 2020 | 13 | 15 | 86.67% |
Q3 2020 | 5 | 11 | 45.45% |
Q1 2020 | 5 | - | - |
Q3 2019 | 8 | - | - |
Q2 2019 | 4 | 7 | 57.14% |
Q1 2019 | 5 | - | - |
Q3 2018 | 3 | - | - |
Q2 2018 | 4 | - | - |
Q1 2018 | 6 | - | - |
Q4 2017 | 1 | - | - |
10 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Eledon Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 6 | - | - |
Q4 2023 | - | - | - |
Q2 2023 | 9 | - | - |
Q1 2023 | - | - | - |
Q4 2022 | 1 | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 1 | - | - |
Q3 2021 | 1 | - | - |
Q2 2021 | 2 | - | - |
Q1 2021 | - | - | - |
Q4 2020 | 7 | 3 | 233.33% |
Q3 2020 | - | - | - |
Q1 2020 | - | 2 | - |
Q3 2019 | - | - | - |
Q2 2019 | 4 | 7 | 57.14% |
Q1 2019 | - | - | - |
Q3 2018 | 3 | - | - |
Q2 2018 | - | - | - |
Q1 2018 | - | - | - |
Q4 2017 | - | - | - |
As of Q2 2024, Insider owners conducted 6 open market buy trades and 0 open market sell trades of Eledon Pharmaceuticals's stocks.
ELDN Ownership FAQ
Who Owns Eledon Pharmaceuticals?
Eledon Pharmaceuticals is owned by institutional shareholders (60.89%), insiders (3.41%), and public (35.70%). The largest institutional shareholder of Eledon Pharmaceuticals is BVF INC/IL (20.98% of total shares) and the top mutual fund owner is FIDELITY ADVISOR SERIES VII (0.01% of total shares).
Who are the major institutional shareholders of Eledon Pharmaceuticals?
Eledon Pharmaceuticals's major institutional shareholders are BVF INC/IL, ARMISTICE CAPITAL, LLC, ZIMMER PARTNERS, LP, SCHONFELD STRATEGIC ADVISORS LLC, and SPHERA FUNDS MANAGEMENT LTD.. The top five shareholders own together 45.14% of the company's share outstanding.
How many Eledon Pharmaceuticals shareholders are there?
As of Jun 2024, there are 31 institutional shareholders of Eledon Pharmaceuticals.
What percentage of Eledon Pharmaceuticals is owned by BVF INC/IL?
BVF INC/IL owns 6.29M shares of Eledon Pharmaceuticals, representing 20.98% of the company's total shares outstanding, valued at $16.61M (as of Jun 2024).
What percentage of Eledon Pharmaceuticals is owned by ARMISTICE CAPITAL, LLC?
As of Jun 2024, ARMISTICE CAPITAL, LLC holds 2.34M shares of Eledon Pharmaceuticals (ELDN), compromising 7.79% of the company, valued at $6.17M.
What percentage of Eledon Pharmaceuticals is owned by ZIMMER PARTNERS, LP?
ZIMMER PARTNERS, LP is the third largest holder of Eledon Pharmaceuticals. The company owns 2.11M of the company's shares outstanding (worth $5.57M).